407 related articles for article (PubMed ID: 33953366)
1. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
Fakhouri F; Frémeaux-Bacchi V
Nat Rev Nephrol; 2021 Aug; 17(8):543-553. PubMed ID: 33953366
[TBL] [Abstract][Full Text] [Related]
2. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
[TBL] [Abstract][Full Text] [Related]
3. Genetics of atypical hemolytic uremic syndrome (aHUS).
Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
[TBL] [Abstract][Full Text] [Related]
4. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
Cavero T; Arjona E; Soto K; Caravaca-Fontán F; Rabasco C; Bravo L; de la Cerda F; Martín N; Blasco M; Ávila A; Huerta A; Cabello V; Jarque A; Alcázar C; Fulladosa X; Carbayo J; Anaya S; Cobelo C; Ramos N; Iglesias E; Baltar J; Martínez-Gallardo R; Pérez L; Morales E; González R; Macía M; Draibe J; Pallardó L; Quintana LF; Espinosa M; Barros X; Pereira F; Cao M; Moreno JA; Rodríguez de Córdoba S; Praga M;
Kidney Int; 2019 Oct; 96(4):995-1004. PubMed ID: 31420192
[TBL] [Abstract][Full Text] [Related]
5. Defining the genetics of thrombotic microangiopathies.
Vieira-Martins P; El Sissy C; Bordereau P; Gruber A; Rosain J; Fremeaux-Bacchi V
Transfus Apher Sci; 2016 Apr; 54(2):212-9. PubMed ID: 27177491
[TBL] [Abstract][Full Text] [Related]
6. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
Martins M; Bridoux F; Goujon JM; Meuleman MS; Ribes D; Rondeau E; Guerry MJ; Delmas Y; Levy B; Ducloux D; Kandel-Aznar C; Le Fur A; Garrouste C; Provot F; Gibier JB; Thervet E; Bruneval P; Rabant M; Karras A; Dragon Durey MA; Fremeaux-Bacchi V; Chauvet S
Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
Sperati CJ; Moliterno AR
Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.
Halimi JM; Al-Dakkak I; Anokhina K; Ardissino G; Licht C; Lim WH; Massart A; Schaefer F; Walle JV; Rondeau E
J Nephrol; 2023 Apr; 36(3):817-828. PubMed ID: 36152218
[TBL] [Abstract][Full Text] [Related]
9. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
Front Immunol; 2022; 13():909503. PubMed ID: 35720299
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
[TBL] [Abstract][Full Text] [Related]
11. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
Kistler AD
Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H
Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
[TBL] [Abstract][Full Text] [Related]
13. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.
Gaggl M; Aigner C; Csuka D; Szilágyi Á; Prohászka Z; Kain R; Haninger N; Knechtelsdorfer M; Sunder-Plassmann R; Sunder-Plassmann G; Schmidt A
J Am Soc Nephrol; 2018 Mar; 29(3):1020-1029. PubMed ID: 29282226
[TBL] [Abstract][Full Text] [Related]
14. Carfilzomib-induced atypical haemolytic uraemic syndrome: a diagnostic challenge and therapeutic success.
Darwin A; Malpica L; Dhanoa J; Hashmi H
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637496
[TBL] [Abstract][Full Text] [Related]
15. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic Microangiopathy in Inverted Formin 2
Challis RC; Ring T; Xu Y; Wong EK; Flossmann O; Roberts IS; Ahmed S; Wetherall M; Salkus G; Brocklebank V; Fester J; Strain L; Wilson V; Wood KM; Marchbank KJ; Santibanez-Koref M; Goodship TH; Kavanagh D
J Am Soc Nephrol; 2017 Apr; 28(4):1084-1091. PubMed ID: 27974406
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
20. Eculizumab in secondary atypical haemolytic uraemic syndrome.
Cavero T; Rabasco C; López A; Román E; Ávila A; Sevillano Á; Huerta A; Rojas-Rivera J; Fuentes C; Blasco M; Jarque A; García A; Mendizabal S; Gavela E; Macía M; Quintana LF; María Romera A; Borrego J; Arjona E; Espinosa M; Portolés J; Gracia-Iguacel C; González-Parra E; Aljama P; Morales E; Cao M; Rodríguez de Córdoba S; Praga M
Nephrol Dial Transplant; 2017 Mar; 32(3):466-474. PubMed ID: 28339660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
